Cargando…

Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis

BACKGROUND: In the past decade, fibroblast growth factor 23 (FGF23) has been recognized as an important biomarker of cardiovascular diseases. This study aimed to assess the relationship between FGF23 and the risk of cardiovascular diseases (CVDs) in general populations. METHODS: The protocol was reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Menglu, Xia, Panpan, Tan, Ziqi, Song, Tiangang, Mei, Kaibo, Wang, Jingfeng, Ma, Jianyong, Jiang, Yuan, Zhang, Jing, Zhao, Yujie, Yu, Peng, Liu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669381/ https://www.ncbi.nlm.nih.gov/pubmed/36407457 http://dx.doi.org/10.3389/fcvm.2022.989574

Ejemplares similares

Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis
por: Tan, Ziqi, et al.
Publicado: (2022)

Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis
por: Liu, Xiao, et al.
Publicado: (2022)

The Prevalence and Associated Death of Ventricular Arrhythmia and Sudden Cardiac Death in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Tan, Ziqi, et al.
Publicado: (2022)

Hyperuricemia Is Associated With the Risk of Atrial Fibrillation Independent of Sex: A Dose-Response Meta-Analysis
por: Xiong, Jianhua, et al.
Publicado: (2022)

Influenza vaccination is associated with a decreased risk of atrial fibrillation: A systematic review and meta-analysis
por: Liu, Menglu, et al.
Publicado: (2022)

Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis
por: Liu, Fuwei, et al.
Publicado: (2023)

Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis
por: Liu, Menglu, et al.
Publicado: (2022)

Impact of body mass index on procedural complications, procedure duration, and radiation dose in patients with atrial fibrillation undergoing radiofrequency ablation: A systematic review and meta‐analysis
por: Liu, Menglu, et al.
Publicado: (2020)

Dose-response relationship among body mass index, abdominal adiposity and atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of 35 cohorts
por: Liu, Menglu, et al.
Publicado: (2021)

Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta‐Analysis
por: Zhao, Huilei, et al.
Publicado: (2023)

Atrial fibrillation and breast cancer—Vicious twins? A systematic review and meta-analysis
por: Yao, Xiongda, et al.
Publicado: (2023)

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population
por: Bracun, Valentina, et al.
Publicado: (2021)

Association of Total Bilirubin With All-Cause and Cardiovascular Mortality in the General Population
por: Chen, Ziwei, et al.
Publicado: (2021)

Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry
por: Schmitz, Timo, et al.
Publicado: (2023)

The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population
por: Liu, Xiao-cong, et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes
por: Zhao, Huilei, et al.
Publicado: (2020)

Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: a systematic review and dose–response meta-analysis
por: Zhao, Huilei, et al.
Publicado: (2023)

Periodontal disease is associated with the risk of cardiovascular disease independent of sex: A meta-analysis
por: Leng, Yurong, et al.
Publicado: (2023)

Editorial: Insights in General Cardiovascular Medicine: 2021
por: Wang, Lijun, et al.
Publicado: (2022)

The Burden of Ventricular Premature Complex Is Associated With Cardiovascular Mortality
por: Lee, Po-Tseng, et al.
Publicado: (2022)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study
por: He, Di, et al.
Publicado: (2021)

Estimated pulse wave velocity is associated with all-cause mortality and cardiovascular mortality among adults with diabetes
por: Wu, Li-Da, et al.
Publicado: (2023)

The association of central and extremity circumference with all-cause mortality and cardiovascular mortality: a cohort study
por: Liu, Jiajun, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)

A U-Shaped Relationship Between Selenium Concentrations and All-Cause or Cardiovascular Mortality in Patients With Hypertension
por: Tan, Qiu-hong, et al.
Publicado: (2021)

Editorial: Methods in general cardiovascular medicine
por: Fazio, Serafino, et al.
Publicado: (2023)

The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
por: Huang, Yu, et al.
Publicado: (2023)

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors
por: Wang, Zhipeng, et al.
Publicado: (2023)

Association of serum copper (Cu) with cardiovascular mortality and all-cause mortality in a general population: a prospective cohort study
por: Li, Xiaozhong, et al.
Publicado: (2023)

Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022)

Obesity increases cardiovascular mortality in patients with HFmrEF
por: Liu, Zhican, et al.
Publicado: (2022)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
por: Qiu, Mei, et al.
Publicado: (2021)

Editorial: Highlights in General Cardiovascular Medicine: 2021
por: Wang, Lijun, et al.
Publicado: (2022)

Editorial: Insights in general cardiovascular medicine: 2022
por: Acampa, Maurizio, et al.
Publicado: (2023)

Sharing risk management: an implementation model for cardiovascular absolute risk assessment and management in Australian general practice
por: Wan, Q, et al.
Publicado: (2008)

UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database
por: Lee, Sally, et al.
Publicado: (2011)

Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose–Response Meta-Analysis of Prospective Studies
por: Cao, Yalin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1q8jesjrnr5mp895stuugpq5nd